Optum

• NCT04974580

  Collaborator, Phase 4, Completed, 508 people, 23 Jul 2021

• A Simplified Metric to Streamline Between-Group Fairness Assessment for Predictive Models: Algorithm Development and Evaluation Study

  Employment, 24 Aug 2026

• Association between rheumatoid arthritis, frailty status, mortality and anti-cancer therapy: a retrospective SEER-Medicare analysis in patients with non-metastatic renal cell carcinoma

  Consulting or advice, 11 Aug 2026

• Dementia in Advanced Kidney Disease by Race and Ethnicity and Neighborhood Factors

  Consulting or advice, 28 Jul 2026

Sources: pubmed.ncbi.nlm.nih.gov, europepmc.org

• Association of GLP-1 Use and End-Stage Liver Disease (ESLD) Events in U.S. Adults with Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)

  ADA Scientific Sessions 2026 abstract, 5 Jun 2026

• Real-World HbA1c and Weight Change after 6 and 12 Months by GLP-1 Treatment Persistence in Adults with Type 2 Diabetes

  ADA Scientific Sessions 2026 abstract, 5 Jun 2026

• Sildenafil is a candidate drug for Alzheimer’s disease: Mechanism‐of‐action observation in patient iPSC‐derived brain organoids and a 5xFAD mouse model

  AAIC 2025 abstract, 26 Dec 2025

• Location Matters: The Role of the Neighborhood Environment for Incident Cardiometabolic Disease in Adults Aging With Physical Disability

  American journal of health promotion : AJHP, 18 Jan 2024